ProC® global: The first functional screening assay for the complete protein C pathway

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1719-1723

  Dati, Francesco ^a,b   Hafner, Gerd ^a   Erbes, Hilde ^a   Prellwitz, Winfried ^a   Kraus, Michael ^a   Niemann, Frank ^a   Noah, Michael ^a   Wagner, Carola ^a  

^a Behring Diagnostics GmbH   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; PROTEIN C; PROTEIN S; PROTHROMBIN; SNAKE VENOM; THROMBOPLASTIN; BLOOD CLOTTING FACTOR 5 LEIDEN;

BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING TIME; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PROTHROMBIN TIME; THROMBOPHILIA; THROMBOSIS; VEIN THROMBOSIS; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; BLOOD CLOTTING DISORDER; BLOOD DONOR; COMPARATIVE STUDY; DISEASE PREDISPOSITION; INSTRUMENTATION; MASS SCREENING; METHODOLOGY; MUTATION; REFERENCE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

SERPENTES;

BLOOD COAGULATION DISORDERS; BLOOD DONORS; DISEASE SUSCEPTIBILITY; FACTOR V; HUMANS; MASS SCREENING; MUTATION; PARTIAL THROMBOPLASTIN TIME; PROTEIN C; PROTEIN C DEFICIENCY; PROTEIN S; REAGENT KITS, DIAGNOSTIC; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THROMBOSIS;

EID: 0030609944     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1719     Document Type: Conference Paper

References (10)

1. Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, et al. Inherited thrombophilia: part 1. Thromb Haemost 1996;76:651-62.
2. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci USA 1993:90:1004-8.
3. Koster T, Rosendaal RF, de Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993:342:1503-6.
4. Esmon CT. Protein S and protein C - biochemistry, physiology and clinical manifestation of deficiencies. Trends Cardiovasc Med 1992:2:214-9.
5. Cavenagh JD, Colvin BT. Guidelines for the management of thrombophilia. Postgrad Med J 1996:72:87-94.
6. Kraus M, Noah M, Fickenscher K. The PCAT - a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res 1995;79:217-22.
7. Halbmayer WM, Angerer V, Rscher M, Wagner C. First experience with a new functional screening assay for the protein C pathway-ProC Global [Abstract]. Thromb Haemost 1997(Suppl):30.
8. Koster T, Rosendaal FR, Briët E, van der Meer FJ, Colly LP, Trienekens PH, et al. Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study). Blood 1995;85: 2756-61.
9. Koster T, Rosendaal FR, Reitsma PH, van der Velden PA, Briët E, Vandenbroucke JP. Factor VII and fibrinogen levels as risk factors for venous thrombosis. Thromb Haemost 1994;71:719-22.
10. Koster T, Blaun AD, Briët E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152-5.